Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.
Costa VV, Sugimoto MA, Hubner J, Bonilha CS, Queiroz-Junior CM, Gonçalves-Pereira MH, Chen J, Gobbetti T, Libanio Rodrigues GO, Bambirra JL, Passos IB, Machado Lopes CE, Moreira TP, Bonjour K, Melo RCN, Oliveira MAP, Andrade MVM, Sousa LP, Souza DG, Santiago HDC, Perretti M, Teixeira MM.
Costa VV, et al. Among authors: souza dg.
Elife. 2022 Mar 16;11:e73853. doi: 10.7554/eLife.73853.
Elife. 2022.
PMID: 35293862
Free PMC article.